Worth reading
61In focus
Scored from 4 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
202000000
¥Wording
Conditional
How definitive the wording is.Decision and Details
Expected recognition of a gain on the sale of investment securities (extraordinary income)
Decision15 October 2026
ImplementationScheduled for sale on or after 16 October 2026 (over approximately 1 month)
Going forwardThe securities are scheduled to be sold over approximately 1 month from 16 October 2026, taking market conditions into consideration. The sale is already reflected in the revision to the full-year earnings forecast for the fiscal year ending November 2026
AmountGain on sale of investment securities: approximately ¥202 million (expected)
Quantity / scale2 listed securities held by the company; scheduled sale period of approximately 1 month
Reason
To reduce and review cross-shareholdings in accordance with the Corporate Governance Code and strengthen the company's financial position
Impact on Business Performance
The gain on sale of investment securities is already included in the full-year earnings forecast for the fiscal year ending November 2026
| Item | Details |
|---|---|
| Matter Covered | Expected recognition of a gain on the sale of investment securities (extraordinary income) |
| Decision Date | 15 October 2026 |
| Implementation Date | Scheduled for sale on or after 16 October 2026 (over approximately 1 month) |
| Amount | Gain on sale of investment securities: approximately ¥202 million (expected) |
| Quantity / scale | 2 listed securities held by the company; scheduled sale period of approximately 1 month |
| Impact on Business Performance | The gain on sale of investment securities is already included in the full-year earnings forecast for the fiscal year ending November 2026 |
| Reason | To reduce and review cross-shareholdings in accordance with the Corporate Governance Code and strengthen the company's financial position |
| Governing Rule | Corporate Governance Code |
| Future plans | The securities are scheduled to be sold over approximately 1 month from 16 October 2026, taking market conditions into consideration. The sale is already reflected in the revision to the full-year earnings forecast for the fiscal year ending November 2026 |
Items this document does not state (3)
Decision-Making BodyPeriod CoveredRelated previous disclosures
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To reduce and review cross-shareholdings and strengthen the company's financial position.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.